Knowledge Center

Article / Jan 01, 2011

What is Special About Inhalation APIs?

Authors:
  • Carla Vozone
Source:
Drug Development and Delivery, January 2011

What is Special About Inhalation APIs? Drug Development Executive: Carla Vozone, Director of Business Development for Hovione's Generics Business Unit, discusses what makes Hovione unique in API supply for inhalation, its supportive technologies, and approach to the market.

Related links

Read article here

Also in the Knowledge Center

Related Content

Quality by Design

Pioneering Quality by Design (QbD) for Process Development.

Page
Read more

Hovione and Firstgene announce strategic collaboration to advance virus-like particle platform for liver cancer

Press Release / May 06, 2025
Article
View

Drug delivery platforms

Hovione has unique capabilities and expertise in solubility enhancement, lung delivery, modified release and taste-masking applications.

Page
Read more